quinidine has been researched along with kanamycin a in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hughes, IE; Ilett, KF; Jellett, LB | 1 |
| Ando, K; Takada, K | 1 |
| Clark, WW; Pearson, RD; Stebbins, WC; Weiland, NG | 1 |
| ATRIA, NF; WADSWORTH, GL | 1 |
1 review(s) available for quinidine and kanamycin a
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for quinidine and kanamycin a
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The use of kanamycin in equilibrium dialysis at 37 degrees.
Topics: Animals; Blood Proteins; Dialysis; Dogs; Female; Haloperidol; Humans; In Vitro Techniques; Kanamycin; Male; Propranolol; Protein Binding; Quinidine; Salicylates; Temperature | 1975 |
Trialwise tracking method for measuring drug-affected sensory threshold changes in animals.
Topics: Animals; Auditory Perception; Auditory Threshold; Conditioning, Operant; Kanamycin; Lysergic Acid Diethylamide; Macaca mulatta; Male; Pilocarpine; Quinidine; Rats; Rats, Inbred Strains; Sensory Thresholds; Visual Perception | 1979 |
Noise-and drug-induced hearing loss in monkeys.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Conditioning, Operant; Deafness; Disease Models, Animal; Haplorhini; Hearing Loss, Noise-Induced; Kanamycin; Macaca; Methods; Neomycin; Papio; Quinidine; Sodium Salicylate; Time Factors | 1973 |
Drug-induced deafness.
Topics: Adult; Anti-Bacterial Agents; Aspirin; Deafness; Drug-Related Side Effects and Adverse Reactions; Ethacrynic Acid; Gentamicins; Glycosides; Humans; Injections, Intravenous; Kanamycin; Male; Middle Aged; Neomycin; Paromomycin; Quinidine | 1973 |
TWO YEARS EXPERIENCE WITH SHIGELLOSIS IN A HOSPITAL AND SCHOOL FOR THE MENTALLY RETARDED.
Topics: Anti-Bacterial Agents; Chloramphenicol; Communicable Disease Control; Dysentery, Bacillary; Furazolidone; Kanamycin; Mental Disorders; Morbidity; Oxytetracycline; Paromomycin; Persons with Mental Disabilities; Protein Synthesis Inhibitors; Quinidine; Shigella dysenteriae; Sulfathiazoles; Tetracycline | 1963 |